News
Practice Areas
Int’l Medical Devices, Inc. v. Cornell — Patent disclosures forfeit trade secret protections
Int’l Medical Devices, Inc. v. Cornell
Patent disclosures forfeit trade secret protections
Patent and trade secret laws both protect intellectual property, but sometimes they conflict. Here’s how the existence of patents undermined a plaintiff’s recent trade secret misappropriation case.
Dueling doctors
James Elist is a urologist and owner of International Medical Devices Inc., which manufactures the Penuma® cosmetic penile implant. In 2018, Penuma was the only commercially available cosmetic penile implant. That year, Robert Cornell attended a Penuma surgical training hosted by Elist and signed a nondisclosure agreement (NDA) prohibiting him from disclosing or using confidential information. The NDA excluded information that “was or becomes generally available to the public other than as a result of disclosure” by Cornell. During the training, Elist disclosed several ideas for improving the implant.
Elist subsequently alleged, among other things, that Cornell misappropriated trade secrets (including improvement ideas) to develop a competing cosmetic implant named Augmenta. At trial, the jury ruled for Elist, finding that each improvement idea was a protectable and misappropriated trade secret. The trial court also imposed a permanent injunction barring Cornell from using the trade secrets for five years. Cornell appealed to the U.S. Court of Appeals for the Federal Circuit.
Sabotaged secrecy
Cornell argued that three of the alleged trade secrets were concepts that had been disclosed in two publicly available patents issued years earlier. Elist countered that, because none of the concepts were ever actually implemented in real-world products, the trade secrets weren’t generally known.
The Federal Circuit, however, pointed out that it had repeatedly held that what’s disclosed in a patent is “generally known to the public” and can’t, therefore, be a trade secret. Once information is in the public domain, the element of secrecy is gone. The patent disclosures made the alleged trade secrets generally known even if they were never embodied in actual products.
The court rejected Elist’s contention that a patent for a therapeutic implant (such as one of the patents cited by Cornell) couldn’t disclose a trade secret related to a cosmetic implant like Penuma, which was designed to increase penile size. No protectable trade secret results from translating a generally known concept from one environment to another if both environments present the same problem solved by the same solution.
Power of the patent
The appellate court’s decision affirms the principle that what’s disclosed in a patent can’t constitute a trade secret. It doesn’t matter if a patent is owned by a different party, never developed into a product or from a different field — disclosures aren’t protectable as trade secrets.
Int’l Medical Devices, Inc. v. Cornell, No. 25-1580, -1650, April 17, 2026, Fed. Cir.